Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesLow-grade gliomas in older patients
Cancer, 07/01/09
Schomas DA et al. - The retrospective series of older patients suggests that intracranial LGG in this age group behaves aggressively. Pathologic sampling error failing to recognize higher-grade tumors does not seem to account for these poor outcomes. Aggressive management with maximally safe resection followed by adjuvant therapy should be strongly considered.
Nadia N. Laack, 07/24/09
| This review looks at a rare condition in older adults. Typically survival for low-grade gliomas is 5-7 years. These outcomes suggest low grade gliomas behave aggressively in the elderly (more similar to grade 3 or higher grade tumors) and likely should be treated as such. We recommend adjuvant radiotherapy with or without temozolamide chemotherapy after maximally safe resection. |
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Medulloblastoma in childhood: revisiting intrathecal therapy in infants and children
Cancer Chemotherapy and Pharmacology, 10/29/09
Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations
Cancer Management and Research, 11/05/09
Incidence of brain metastases in renal cell carcinoma treated with sorafenib
Annals of Oncology, 10/29/09
Sponsor
Article Search
Sponsor
Sponsor